Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Study Type
OBSERVATIONAL
Enrollment
100
Administer translated COMPAT-SF questionnaires to Spanish-speaking CP patients
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texas, United States
RECRUITINGFace validity:
Patient-reported feedback through a questionnaire concerning the feasibility of the translated COMPAT-SF questionnaire
Time frame: through study completion, up to 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.